Antibody News and Research

RSS
Game-Changers in Western Blotting and Protein Analysis

Game-Changers in Western Blotting and Protein Analysis

Researchers discover key factors behind intestinal inflammation in CVID patients

Researchers discover key factors behind intestinal inflammation in CVID patients

Scientists harness power of natural killer cells to treat children with neuroblastoma

Scientists harness power of natural killer cells to treat children with neuroblastoma

NIH researchers shed light on causes of HBV-associated acute liver failure

NIH researchers shed light on causes of HBV-associated acute liver failure

New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers

New anti-HER2 drug shows promising anti-tumor activity in gullet, stomach and bowel cancers

Breakthrough research could lead to a new wave of cancer-fighting antibodies

Breakthrough research could lead to a new wave of cancer-fighting antibodies

UCI researchers accelerate and simplify directed evolution bioengineering technique

UCI researchers accelerate and simplify directed evolution bioengineering technique

Researchers reveal link between autoimmune and cardiovascular disease in mice

Researchers reveal link between autoimmune and cardiovascular disease in mice

At-risk healthcare workers being vaccinated against Ebola in Uganda

At-risk healthcare workers being vaccinated against Ebola in Uganda

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Amgen announces presentation of new clinical data showcasing early oncology pipeline at ASH 2018

Integral Molecular wins NIH grant to initiate target discovery program for Alzheimer’s disease

Integral Molecular wins NIH grant to initiate target discovery program for Alzheimer’s disease

Measles can be deadly for people with weakened immune systems

Measles can be deadly for people with weakened immune systems

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

Phase III CLL14 study evaluating Venclexta plus Gazyva to treat CLL meets its primary endpoint

New study to evaluate human immune system's response to influenza

New study to evaluate human immune system's response to influenza

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Two-cells-in-one combo therapy shows promise in strengthening leukemia treatment

Scientists describe novel conjugates made from antibodies and protein inhibitor

Scientists describe novel conjugates made from antibodies and protein inhibitor

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

Biogen and Eisai present detailed results from phase 1b study of aducanumab at CTAD meeting

New method to block immunosuppression in cancer discovered

New method to block immunosuppression in cancer discovered

Scientists identify new target for battling deadly form of leukemia

Scientists identify new target for battling deadly form of leukemia

Study uncovers rare phenomenon of antibodies working together against malaria

Study uncovers rare phenomenon of antibodies working together against malaria